Is galectin-3 a useful biomarker in stratifying the risk of heart failure in diabetes?

J Clin Ultrasound. 2023 Nov-Dec;51(9):1436-1438. doi: 10.1002/jcu.23570. Epub 2023 Sep 26.

Authors

Cesare Cuspidi¹, Elisa Gherbesi², Andrea Faggiano^{2

3}

Affiliations

¹ Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
² Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
³ Department of Clinical Sciences and Community Health, University of Milano, Milan, Italy.

PMID: 37750426
DOI: 10.1002/jcu.23570

No abstract available

Keywords: ejection fraction; galectin-3; heart failure; type 2 diabetes.

Publication types

Review
Comment

MeSH terms

Biomarkers
Diabetes Complications* / diagnosis
Diabetes Complications* / genetics
Diabetes Mellitus*
Galectin 3*
Heart Failure* / diagnosis
Humans
Prognosis
Stroke Volume

Substances

Biomarkers
Galectin 3